Literature DB >> 17998789

Malignant sublingual gland tumors: a retrospective clinicopathologic study of 28 cases.

Tao Yu1, Qing-Hong Gao, Xiao-Yi Wang, Yu-Ming Wen, Long-Jiang Li.   

Abstract

OBJECTIVES: To evaluate the clinicopathologic features and therapeutic efficacy of malignant sublingual gland tumors. PATIENTS AND METHODS: From 1955 to 2005, the clinicopathologic data of 28 patients treated in our hospital were obtained from their medical records and histopathologic slides.
RESULTS: There were 16 males and 12 females, with a mean age of 50.3 years. Eighteen cases (64.3%) were adenoid cystic carcinoma; 16 (57.1%) cases were clinically staged as III-IV. Adenoid cystic carcinoma was mainly of the histologic type, and the other histologic classifications included mucoepidermoid carcinoma, myoepithelial carcinoma, polymorphous low-grade adenocarcinoma, adenocarcinoma and malignant pleomorphic adenoma. Pulmonary metastasis and tumor recurrence were the main death reasons. Eleven patients remain alive and well 34-312 months (median 108) after treatment.
CONCLUSIONS: Malignant sublingual gland tumors are extremely rare and most are adenoid cystic carcinoma. Surgery is the main treatment option. For adenoid cystic carcinoma, hematogenous spread is common, and pulmonary metastasis is a common pathway of the distant metastasis. For some patients having lung metastasis, regional control is also important as there are some examples of patients surviving many years with asymptomatic pulmonary metastases. Postoperative radiation therapy may be adjuvant for selected patients with high-stage and high-grade tumors, or when there is concern about the inadequacy of the resection. The effect of chemotherapy remains elusive. Copyright 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2007        PMID: 17998789     DOI: 10.1159/000111087

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  8 in total

1.  [Carcinoma ex pleomorphic adenoma occurring in the sublingual gland: a case report].

Authors:  Chunyuan Luo; Qiang Zhang; Linlin Chen; Yujiang Wang; Weibing Tan
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2014-08

Review 2.  NUT Midline Carcinoma of the Sublingual Gland: Clinical Presentation and Review.

Authors:  Nolan B Seim; Ramez H W Philips; Lynn Schoenfield; Theodoros N Teknos; James W Rocco; Amit Agrawal; Enver Ozer; Ricardo L Carrau; Stephen Y Kang; Matthew O Old
Journal:  Head Neck Pathol       Date:  2017-03-27

3.  Tumors of the sublingual gland: a national clinicopathologic study of 29 cases.

Authors:  Simon Andreasen; K Bjørndal; T K Agander; I Wessel; P Homøe
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-03-25       Impact factor: 2.503

Review 4.  Diagnosis and management of malignant sublingual gland tumors: a narrative review.

Authors:  Minhae Park; Junhun Cho; Junsun Ryu; Han-Sin Jeong
Journal:  Gland Surg       Date:  2021-12

Review 5.  Distant metastasis from oral cavity-correlation between histopathology results and primary site.

Authors:  Yuka Uchiyama; Tadashi Sasai; Atsutoshi Nakatani; Hiroaki Shimamoto; Tomomi Tsujimoto; Sven Kreiborg; Shumei Murakami
Journal:  Oral Radiol       Date:  2020-05-28       Impact factor: 1.852

6.  Risk factors for survival and distant metastasis in 125 patients with head and neck adenoid cystic carcinoma undergoing primary surgery.

Authors:  In Seong Jeong; Jong-Lyel Roh; Kyung-Ja Cho; Seung-Ho Choi; Soon Yuhl Nam; Sang Yoon Kim
Journal:  J Cancer Res Clin Oncol       Date:  2020-03-06       Impact factor: 4.553

7.  Efficacy and safety of anlotinib in metastatic adenoid cystic carcinoma: a retrospective study.

Authors:  Ning Su; Yu Fang; Jinni Wang; Xiaopeng Tian; Shuyun Ma; Jun Cai; Yuchen Zhang; Yi Xia; Panpan Liu; Qingqing Cai
Journal:  Transl Cancer Res       Date:  2022-08       Impact factor: 0.496

Review 8.  Clinical and molecular insights into adenoid cystic carcinoma: Neural crest-like stemness as a target.

Authors:  Wendell G Yarbrough; Alexander Panaccione; Michael T Chang; Sergey V Ivanov
Journal:  Laryngoscope Investig Otolaryngol       Date:  2016-08-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.